Hadi Danaee is an experienced biopharmaceutical professional specializing in the development of cancer therapeutics. Currently serving as Vice President of Translational Medicine at Puma Biotechnology, Hadi leads translational strategies and biomarker initiatives for clinical development programs. Previously, Hadi held positions at Takeda Pharmaceuticals and TESARO, where they focused on biomarker discovery, assay development, and companion diagnostic strategies. Hadi completed a Doctorate in Cancer Biology at the Harvard School of Public Health and holds a Bachelor's degree in Molecular and Cellular Biology from the University of Connecticut.
This person is not in the org chart
This person is not in any teams
This person is not in any offices